AssetMark Inc’s Generation Bio GBIO Stock Holding History

AssetMark Inc’s Portfolio GBIO Stock Details GBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-10	Closed	-$106	–	2671
2024 Q4	$106	Buy	+10	New	+$178	﹤0.01%	2525

Other funds holding GBIO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AssetMark Inc's GBIO Position: Q1 2025 in Review

AssetMark Inc sold out of Generation Bio (GBIO) in Q1 2025, closing a stake of 10 shares — an estimated $106 sold.

AssetMark Inc first reported a position in GBIO in Q4 2024 and held it in 1 quarter. The position peaked at $106 in Q4 2024. 79 funds tracked by Wall St. Rank hold GBIO as of Q1 2025.

AssetMark Inc reported no remaining Generation Bio position as of Q1 2025 after selling out during the quarter.
AssetMark Inc sold 10 Generation Bio shares in Q1 2025, an estimated $106.
AssetMark Inc first reported a position in Generation Bio in Q4 2024 and held it in 1 quarter.
AssetMark Inc's Generation Bio position peaked at $106 in Q4 2024.
79 funds tracked by Wall St. Rank held Generation Bio as of Q1 2025.

Based on AssetMark Inc's 13F filing for Q1 2025, filed 6 May 2025.